A detailed history of Gmt Capital Corp transactions in Ocugen, Inc. stock. As of the latest transaction made, Gmt Capital Corp holds 2,454,958 shares of OCGN stock, worth $2.09 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,454,958
Holding current value
$2.09 Million
% of portfolio
0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.98 - $1.95 $2.41 Million - $4.79 Million
2,454,958 New
2,454,958 $2.43 Million
Q4 2023

Feb 12, 2024

SELL
$0.36 - $0.57 $1.3 Million - $2.06 Million
-3,614,412 Reduced 92.15%
307,786 $175,000
Q2 2023

Aug 10, 2023

BUY
$0.45 - $0.88 $1.76 Million - $3.45 Million
3,922,198 New
3,922,198 $2.12 Million

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $184M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Gmt Capital Corp Portfolio

Follow Gmt Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gmt Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Gmt Capital Corp with notifications on news.